FDA全球物质注册数据库(FDA Global Substance Registration System)
物质名称INAVOLISIB
异名/同义词(2S)-2-((2-((4S)-4-(DIFLUOROMETHYL)-2-OXO-1,3-OXAZOLIDIN-3-YL)-5,6-DIHYDROIMIDAZO(1,2-D)(1,4)BENZOXAZEPIN-9-YL)AMINO)PROPANAMIDE
(2S)-2-((2-((4S)-4-(DIFLUOROMETHYL)-2-OXO-3-OXAZOLIDINYL)-5,6-DIHYDROIMIDAZO(1,2-D)(1,4)BENZOXAZEPIN-9-YL)AMINO)PROPANAMIDE
GDC0077
GDC-0077
INAVOLISIB
INAVOLISIB [INN]
INAVOLISIB [USAN]
INAVOLISIB [WHO-DD]
PROPANAMIDE, 2-((2-((4S)-4-(DIFLUOROMETHYL)-2-OXO-3-OXAZOLIDINYL)-5,6-DIHYDROIMIDAZO(1,2-D)(1,4)BENZOXAZEPIN-9-YL)AMINO)-, (2S)-
RG6114
RG-6114
RO7113755
RO-7113755
CAS登记号2060571-02-8
物质唯一标识(Unique Ingredient Identifier)L4C1UY2NYH
分子式C18H19F2N5O4
国际化合物标识(International Chemical Identifier,InChI)SGEUNORSOZVTOL-CABZTGNLSA-N
SMILESC([C@H](C)Nc1cc2c(-c3n(CCO2)cc(n3)N4C(OC[C@H]4C(F)F)=O)cc1)(=O)N
分子结构式
欧洲化学品管理局注册号(ECHA)
成分类型INGREDIENT SUBSTANCE / chemical
关联数据
  • 药品国际非专利名称数据库
  • 世界卫生组织药物词典
扩展资源
©2006-2024 Drugfuture->FDA Global Substance Registration System